Chelation of cadmium by combining deferasirox and deferiprone in rats

Toxicology and Industrial Health

Volumn 27, Issue 4, 2011, Pages 371-377

  Jamilaldin Fatemi, S ^a   Amir Shokooh Saljooghi, ^b   Faezeh Dahooee Balooch, ^a   Iranmanesh, Marzieh ^a   Mohammad Reza Golbafan, ^a  

^a SHAHID BAHONAR UNIVERSITY OF KERMAN   (Iran)

^b FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

Author keywords

cadmium; Chelation therapy; deferasirox; deferiprone; iron

Indexed keywords

CADMIUM; DEFERASIROX; DEFERIPRONE; IRON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CADMIUM POISONING; CHELATION THERAPY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; MALE; MONOTHERAPY; NONHUMAN; RAT;

ANIMALS; BENZOIC ACIDS; CADMIUM COMPOUNDS; CADMIUM POISONING; CHELATION THERAPY; DRUG COMBINATIONS; IRON CHELATING AGENTS; IRON COMPOUNDS; MALE; PYRIDONES; RATS; RATS, WISTAR; SPECTROPHOTOMETRY, ATOMIC; TRIAZOLES;

RATTUS;

EID: 79955678785     PISSN: 07482337     EISSN: None     Source Type: Journal    
DOI: 10.1177/0748233710388451     Document Type: Article

References (35)

1. Akesson A., Lundh T., Vahter M., Bjellerup P., Lidfeldt J., and Nerbrand C. (2005) Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environmental Health Perspectives, 113: 1627-1631.
2. Amiri A., Fatemi SJ, and Fatemi SN (2007) Removal of Thallium by combining desferrioxamine and deferiprone chelators in rats. Biometals, 20: 159-163.
3. Cappellini MD (2008) Long-term efficacy and safety of deferasirox. Blood Review, 2: 35-41.
4. Clarke ET and Martell AE (1992) Stabilities of 1, 2-dimethyl-3-hydroxypyrid-4-one chelates of divalent and trivalent metal ions. Inorganica Chimica Acta, 19: 57-63.
5. Dalhamn T. and Friberg L. (1955) Dimercaprol (2, 3-dimercaptopropanol) in chronic cadmium poisoning. Acta Pharmacology et Toxicologica, 11(1): 68-71.
6. Fatemi SJ, Amiri A., Bazargan MH, Tubafard S., and Fatemi SN (2007) Clinical evaluation of desferrioxamine (DFO) for removal of thallium ions in rat. International Journal of Artificial Organs, 30: 902-905.
7. Fatemi SJ, Tubafard S., and Nadi B. (2009) Evaluation of the effect of cadmium on rat organs and investigation of diethyl carbamate as an oral drug in treatment of cadmium toxicity. Medicinal Chemistry Research, 18: 179-186.
8. Flora SJS, Bhattacharyan R., and Vijayaraghavan R. (1995) Combined therapeutic potential of mesodimercaptosuccinic acid and calcium edentate on the mobilization and distribution of lead in experimental lead intoxication in rats. Fundamental and Applied Toxicology, 25: 233-240.
9. Gomez W., Esparza JL, Domingo JL, Singha PK, and Jones MM (1988) Comparative aluminium mobilizing action of desferrioxamine and four 3-hydroxypyrid-4-ones in aluminium-loaded rats. Toxicology, 130: 175-181.
10. Hassler CS and Wilkinson KJ (2003) Failure of the biotic ligand and free-ion activity models to explain zinc bioaccumulation by Chlorella kesslerii. Toxicological and Environmental Chemistry, 22: 620-626.
11. Heinz U., Hegetschweiler K., Acklin P., Faller B., Lattmann R., and Schnebli HP (1999) 4-[3,5-Bis (2-hydroxyphenyl)-1,2,4-triazol-1-yl]-benzoic acid: a novel, efficient and selective iron (iii) complexing agent. Angewandte Chemie International Edition, 38: 2568-2571.
12. Henkel G. and Krebs B. (2004) Metallothioneins: zinc, cadmium, mercury, and copper thiolates and selenolates mimicking protein active site features structural aspects and biological implications. Chemistry Review, 104: 801-824.
13. Huang HQ, Cao TM, and Lin QM (2004) Characteristics of trapping copper iron with scrolled ferritin reactor in the flowing seawater. Environmental Science and Technology, 38: 2476-2481.
14. Ivanoviene L., Staneviciene I., Lesaukaite V., Sadauskiene I., and Ivanov L. (2004) Activities of tRNALeu and Leucyl tRNA synthetase and programmed cell death in the liver of mice under experimental cadmium poisoning. Journal of Trace Elements and Electrolytes, 21: 180-184.
15. Jones MM and Cherian MG (1990) The search for chelate antagonists for chronic cadmium intoxication. Toxicology, 62(1):1-25.
16. Kaur G., Srivastava UC, Dwivedi RS, and Srivastava RC (1984) Influence of polyaminocarboxylic acids on the removal of manganese-54 from the body organs of sham-operated and partially hepatectomized rats. Toxicology Letters, 22: 1-6.
17. Kontoghiorghes GJ and Sheppard L. (1987) Simple synthesis of the potent chelators l-alkyl-3-hydroxy -2-mehylpyrid-4-ones. Inorganica Chimica Acta, 136: 111-112.
18. Lifton RP, Gharavi AG, and Geller DS (2001) Molecular mechanisms of human hypertension. Cell, 104: 545-556.
19. Miao AJ, Wang WX, and Juneau P. (2005) Comparison of Cd, Cu, and Zn toxic effects on four marine phytoplankton by pulse-amplitude-modulated fluorometry. Environmental Toxicology and Chemistry, 24: 2603-2611.
20. Mirimanoff N. and Wilkinson KJ (2000) Regulation of Zn accumulation by a freshwater gram-positive bacterium (Rhodococcus opacus). Environmental Science and Technology, 34: 616-622.
21. Neufeld EJ (2006) Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions. Blood, 107(9): 3436-3441.
22. Nisbet-Brown E., Olivieri NF, Giardina PJ, Grady RW, Neufeld EJ, Sechaud R., et al. (2003) Effectiveness and safety of Icl670 in iron-loaded patients with thalassaemia: a placebo-controlled, dose-escalation trial. Lancet, 361: 1597-1602.
23. Satarug S., Nishijo M., Lasker JM, Edwards RJ, and Moore MR (2006) Kidney dysfunction and hypertension: role for cadmium, p450 and heme oxygenases?. The Tohoku Journal of Experimental Medicine, 208: 179-202.
24. Satarug S., Nishijo M., Ujjin P., Vanavanitkun Y., and Moore MR (2005) Cadmium-induced nephropathy in the development of high blood pressure. Toxicology Letters, 157: 57-68.
25. Shimoda R., Nagamine T., Takagi H., Mori M., and Waalkes MP (2001) Induction of apoptosis in cells by cadmium: quantitative negative correlation between basal or induced metallothionein concentration and apoptotic rate. Toxicology Science, 64: 208-215.
26. Shokooh Saljooghi A. and Fatemi SJ. (2010a) Cadmium transport in blood serum. Toxicology and Industrial Health, 26: 195-201.
27. Shokooh Saljooghi A. and Fatemi SJ. (2010b) Clinical evaluation of Deferasirox for removal of cadmium ions in rat. Biometals, 23: 707-712.
28. Shokooh Saljooghi A. and Fatemi SJ (2010c) Removal of Thallium by Deferasirox in rats as biological model. Journal of Applied Toxicology. In press.
29. Steinhauser S., Heinz U., Bartholomä M., Weyhermüller T., Nick H., and Hegetschweiler K. (2004) Complex formation of ICL670 and related ligands with FeIII and FeII. Europian Journal of Inorgorganic Chemistry, 21: 4177-4192.
30. Tubafard S. and Fatemi SJ (2008) Chelation of bismuth by combining desferrioxamine and deferiprone in rats. Toxicology and Industrial Health, 24: 235-240.
31. Tubafard S., Fatemi SJ, Shokooh Saljooghi A., and Torkzadeh M. (2010) Removal of vanadium by combining desferrioxamine and deferiprone chelators in rats. Medicinal Chemistry Research. In press.
32. Waisberg M., Joseph P., Hale B., and Beyersmann D. (2003) Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology, 192: 95-117.
33. Wilde KL, Stauber JL, Markich SJ, Franklin NM, and Brown PL (2006) The effect of pH on the uptake and toxicity of copper and zinc in a tropical freshwater alga (Chlorella sp.). Archives of Environmental Contamination and Toxicology, 51: 174-185.
34. Wood JC, Otto-Duessel M., Gonzalez I., Aguilar MI, Shimada H., Nick H., et al. (2006) Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbil. Translational Research, 148(5): 272-280.
35. Yang LPH, Keam SJ, and Keating GM (2007) Deferasirox: a review of its use in the management of transfusional chronic iron overload. Drugs, 67: 2211-2230.